
Overview
Voxel is a network of diagnostic centers specializing in radiology, nuclear medicine, and advanced technology. The company offers various imaging tests, including CT scans, MRI, PET-CT, SPECT, and fusion biopsy for prostate cancer, as well as treatments like radiosynovectomy and isotope therapy for joint conditions. Voxel has been operating since 2005 and provides online registration for diagnostic examinations.
- ul. Ogrodowa 12, 15-027 Białystok
- ul. Partyzantów 63, 43-300 Bielsko-Biała
- ul. Krakowska 31, 32-700 Bochnia
- ul. Kościuszki 68, 32-800 Brzesko
- ul. Ks. J. Bielawskiego 18, 36-200 Brzozów
Financials
Stock quotes
- Open
- PLN 151.20
- High
- PLN 154.00
- Low
- PLN 148.60
- Volume
- 9.85K
- Avg. vol.
- 11.09K
- Market cap
- PLN 1.6B
- P/E ratio
- 12.86
- EPS
- PLN 11.85
- Shares outstanding
- 10.5M
- 52-week
- PLN 146.20 – 159.60
- Dividend yield
- 1.64%
- Dividend
- PLN 2.50
- Ex dividend date
- Sep 29, 2026
- ISIN
- PLVOXEL00014
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 49.92m | USD 11.66m | USD 8.79m |
| Q1 2026 | USD 42.46m | USD 11.48m | USD 8.62m |
| Q4 2025 | USD 39.08m | USD 8.51m | USD 6.23m |
| Q3 2025 | USD 35.90m | USD 9.21m | USD 6.92m |
Results for Q3 2026:Nov 26, 2026
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.
Results vs industry
Industry
Offer
- Computed tomography
- Magnetic resonance imaging
- PET-CT scan
- SPECT scan
- Prostate fusion biopsy
- DaTSCAN examination
- Radiosynovectomy
- Gamma Knife radiosurgery
Websites
The sites are available in: Polish and English.
- voxel.plVoxel S.A. - diagnostyka obrazowa i terapiaWordPressGoogle AnalyticsGoogle Tag ManagerMeta PixelYoast SEOPPolylangApache
- twojepluca.plProgram profilaktyki raka płucMeta PixelApache
Public procurement
36 tenders recorded as contractor: 7 national ($808,878) and 29 EU ($14,937,928).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 26, 2026 | Supply of medicinal products and radiopharmaceuticals | $273.7K$273,663 | Zagłębiowskie Centrum Onkologii Szpital Specjalistyczny Im. Sz. Starkiewicza w Dąbrowie Górniczej | |
| Sep 29, 2026 | Supply of radioisotope materials | $164.4K$164,357 | Mazowiecki Szpital Wojewódzki Im. Św. Jana Pawła II w Siedlcach sp. z o.o. | |
| Sep 15, 2026 | Provision of PET-CT and choline PET-CT examinations for oncological diagnoses using group I and II radiopharmaceuticals for 5 WSZKzP SPZOZ in Kraków | $268.8K$268,755 | 5 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej |
The company is the contractor in 10 public sector contracts, worth USD 2.50m in total. They were signed with 7 public buyers.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 21, 2026 | udzielanie przez Przyjmującego Zamówienie świadczeń zdrowotnych w zakresie wykonywania badań rezonansu magnetycznego piersi – mammografia MR, w ramach diagnostyki DILO, na potrzeby Szpitala | $8,428 | 5 Wojskowy Szpital Kliniczny z Polikliniką-Samodzielny Publiczny Zakład Opieki Zdrowotnej w Krakowie | |
| Oct 20, 2026 | Supply of medicinal products and radiopharmaceuticals - Lot 5 - Supply of radiopharmaceuticals to the PET-CT Laboratory at ZMN | $235,575 | Zagłębiowskie Centrum Onkologii Szpital Specjalistyczny Im. Sz. Starkiewicza w Dąbrowie Górniczej | |
| Oct 20, 2026 | Supply of medicinal products and radiopharmaceuticals – Lot 6 – Supply of 18 F Choline | $50,243 | Zagłębiowskie Centrum Onkologii Szpital Specjalistyczny Im. Sz. Starkiewicza w Dąbrowie Górniczej |
Voxel has been a party to 16 cases before the National Appeal Chamber (since 2013). It filed 9 appeals (3 upheld, 5 dismissed, 1 discontinued). In 7 cases it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Mar 21, 2025 | Error in price calculation | Dismissed | Wielkopolskie Centrum Onkologii w Poznaniu | |
| Oct 2, 2023 | Description of the subject matter of the procurement | Discontinued | Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji w Warszawie | |
| Jun 14, 2022 | Order | Authority accepted the complaints | Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii |
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2008. In 2026 it is performing 24 contracts with a total value of USD 68.02m. All its contracts were worth USD 485.53m in total.
NFZ contract value by year (in m USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Outpatient specialist care | śląskie | 1 | USD 10.59m |
| Outpatient specialist care | małopolskie | 1 | USD 9.88m |
| Separately contracted healthcare services | śląskie | 1 | USD 7.04m |
| Separately contracted healthcare services | łódzkie | 1 | USD 6.50m |
| Outpatient specialist care | podkarpackie | 1 | USD 4.71m |
NFZ waiting lists
This company's facilities run 48 NFZ waiting lists. Waiting time forecast by NFZ, as of 11.11.2026.
| Service | Facility | Waiting time | Urgent | Waiting | |
|---|---|---|---|---|---|
| Isotope therapy | Brzozów | 3 days | 2 days | 1 | |
| Computed tomography | Jelenia Góra | 7 days | 5 days | 87 | |
| Positron emission tomography | Brzozów | 10 days | 8 days | 57 | |
| Positron emission tomography | Rzeszów | 12 days | 7 days | 40 | |
| Nuclear medicine examinations | Brzozów | 15 days | 14 days | 61 |
Trademarks
The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2009.
| Mark | Protected until | |
|---|---|---|
| voxel | May 11, 2029 |
Job offers
The company lists 6 job openings on its own careers page: voxel.pl/grupa-voxel/kariera.
Authorized Representatives
Manner of representation
Two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorized to submit declarations of will and sign documents on behalf of the company.
Supervisory board
Beneficial owners
Voxel is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Exira Gamma Knife sp. z o.o. | 2,742,585.09 USD | 100% | ||
Voxel Inwestycje sp. z o.o. | 783,360.35 USD | 100% | ||
Alteris S.A. | 284,668.56 USD | 100% |
Capital group
The company is the parent company of a corporate group.
| Name | Ownership |
|---|---|
Inwestycje sp z o.o. | 100% |
| 100% | |
| 63.73% |
Bank accounts
Registered as a VAT taxpayer on 2005-07-01.
09 2490 0005 0000 4600 8767 4393
73 2490 0005 0000 4600 6980 0991
17 2490 0005 0000 4600 8473 3403
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 22, 2019 | Other notice | |
| Dec 10, 2015 | Other notice | |
| Apr 29, 2013 | Commercial Companies Code notice | |
| Nov 30, 2012 | Other notice |
Public aid
8 public aid cases recorded, with a total value of $2,120,126.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 26, 2023 | Aid for research and development projects: industrial research | $914.7K$914,667 | Prezes Agencji Badań Medycznych | |
| Jan 26, 2023 | Aid for research and development projects: experimental development | $199.2K$199,189 | Prezes Agencji Badań Medycznych | |
| Feb 10, 2020 | Aid for research and development projects: experimental development | $329.8K$329,751 | Marszałek Województwa Małopolskiego |
European Funds
4 projects co-financed from European Funds recorded, with total EU co-financing of $1,011,234.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-03-01 | Conducting research and development work aimed at implementing a process innovation based on artificial intelligence in MRI diagnostic imaging facilities | $329.9K$329,925 | Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020 | |
| 2020-01-21 | Expansion of the R&D department to conduct research on new radiopharmaceuticals | $221.6K$221,612 | Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020 | |
| 2019-03-01 | Development work to implement an innovative technology for a new line of radiopharmaceuticals | $403.4K$403,433 | Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Kliniki Neuroradiochirurgii sp. z o.o. | $74,127,950.61 | onkologiaradom.pl | ||
| Tomma Diagnostyka Obrazowa S.A. | $41,423,915.29 | tomma.com.pl | ||
| Salve Medica sp. z o.o. + limited partnership | $40,755,913.41 | salvemedica.pl | ||
| Affidea Onkoterapia sp. z o.o. | $29,529,691.81 | affidea.pl | ||
| NU - Med Grupa S.A. | $25,775,184.94 | nu-med.pl | ||
| Wizja V sp. z o.o. | $21,972,545.79 | wizjamed.pl | ||
| Polmed Diagnostyka sp. z o.o. | $19,099,698.64 | polmeddiagnostyka.pl | ||
| Mruk-MED I sp. z o.o. | $16,781,974.03 | mrukmed.pl | ||
| Centrum Diagnostyki Medycznej Multi-Med S.A. | $14,036,138.38 | multimed.pl | ||
| Diagnostyka Wyrobek sp. z o.o. | $13,516,275.46 | jutrzenki100.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-09-05 | Switch to PKD 2025 (6 PKD 2007 codes → 6 PKD 2025 codes) | |
| 2019-10-03 | PKD change (Removed: 53 codes) | |
| 2013-07-31 | Share capital increase (10,402,600.00 PLN → 10,502,600.00 PLN) | |
| 2013-04-18 | Share capital increase (9,732,600.00 PLN → 10,402,600.00 PLN) | |
| 2013-03-15 | PKD change (Added: 8 codes) |
FAQ
Last updated: 2026-07-31